|
|
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2002-10-3230.

Submitted October 24, 2002
Accepted March 21, 2003
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-center case-control study
Alfonso Mele*, Alessandro Pulsoni, Elvira Bianco, Pellegrino Musto, Andre Szklo, Maria Grazia Sanpaolo, Emilio Iannitto, Amalia De Renzo, Bruno Martino, Vincenzo Liso, Cristina Andrizzi, Simona Pusterla, Fausto Dore, Maddalena Maresca, Maria Rapicetta, Fabrizio Marcucci, Franco Mandelli, and Silvia Franceschi
Epidemiologia Clinica, Istituto Superiore di Sanita, Rome, Italy
'La Sapienza' University, Rome, Italy
Department of Haematology, IRCCS 'Casa Sollievo e Sofferenza' Hospital, San Giovanni Rotondo, Italy
Department of Haematology, University of Palermo, Palermo, Italy
'Federico II' University, Naples, Italy
'Riuniti' Hospital, Reggio Calabria, Italy
Department of Haematology, University of Bari, Bari, Italy
Department of Haematology, Montefiascone Hospital, Montefiascone, Italy
'Riuniti' Hospital, Bergamo, Italy
University of Sassari, Sassari, Italy
'Catholic' University, Rome, Italy
Chief, Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France
* Corresponding author; email: amele{at}iss.it.
Background: The existence of an association between infection with hepatitis C virus (HCV) and B-cell non-Hodgkin Lymphoma (B-NHL) remains controversial, largely because previous studies were based on prevalent case-series or comparisons with less than optimal control groups.
Objective: To evaluate the association between HCV infection and B-NHL of different type. Design: Hospital-based case-control study. Setting: Haematological departments of ten hospitals in different Italian cities. Patients and Methods: The study was conducted from January 1998 through February 2001. The cases consisted of consecutive patients with a new diagnosis of B-NHL; the controls were patients in other departments of the same hospitals. Both groups were interviewed using a standardised questionnaire. The prevalence of HCV infection was calculated by type of B-NHL and degree of histological differentiation (low grade and high grade). Adjusted odds ratios (OR) and HCV-attributable risk (AR) were estimated. Results: The HCV prevalence was 17.7% among the 401 cases and 5.6% among the 396 controls. The OR of B-NHL (cases vs. controls), adjusted by age, sex, level of education and place of birth, was 3.1 (95% Confidence Interval, IC 1.8-5.2); an OR indicative of positive association was also found for both low-grade and high-grade B-NHL. The estimated AR was 4.6%. Conclusions: The study confirms an association between HCV and B-NHL. In Italy one out of 20 of B-NHL may be attributable to HCV infection and may, thus, benefit of anti-viral treatment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Paulli, L. Arcaini, M. Lucioni, E. Boveri, D. Capello, F. Passamonti, M. Merli, S. Rattotti, D. Rossi, R. Riboni, et al.
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Ann. Onc.,
October 25, 2009;
(2009)
mdp454v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Terrier, D Sene, D Saadoun, P Ghillani-Dalbin, V Thibault, A Delluc, J-C Piette, and P Cacoub
Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders
Ann Rheum Dis,
January 1, 2009;
68(1):
89 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Hsieh, H.-H. Huang, C.-Y. Lin, L. W. Chung, Y.-M. Liao, L.-Y. Bai, and C.-F. Chiu
Rituximab-Induced Hepatitis C Virus Reactivation After Spontaneous Remission in Diffuse Large B-Cell Lymphoma
J. Clin. Oncol.,
May 20, 2008;
26(15):
2584 - 2586.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Saadoun, D. A. Landau, L. H. Calabrese, and P. P. Cacoub
Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation
Rheumatology,
August 1, 2007;
46(8):
1234 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sansonno, A. Carbone, V. De Re, and F. Dammacco
Hepatitis C virus infection, cryoglobulinaemia, and beyond
Rheumatology,
April 1, 2007;
46(4):
572 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Arnaud, M-C Escande, M Lecuit, P Validire, C Levy, C Plancher, A Vincent-Salomon, N Brousse, P de Cremoux, O Hermine, et al.
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Ann. Onc.,
February 1, 2007;
18(2):
400 - 401.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Arcaini, S Burcheri, A Rossi, M Paulli, R Bruno, F Passamonti, E Brusamolino, A Molteni, A Pulsoni, M. Cox, et al.
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Ann. Onc.,
February 1, 2007;
18(2):
346 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ferreri, R Dolcetti, P Musto, G. Dognini, C Doglioni, and M Ponzoni
Reply to the article 'Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)' by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369)
Ann. Onc.,
February 1, 2007;
18(2):
401 - 403.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dal Maso and S. Franceschi
Hepatitis C Virus and Risk of Lymphoma and Other Lymphoid Neoplasms: A Meta-analysis of Epidemiologic Studies.
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2006;
15(11):
2078 - 2085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Visco, L Arcaini, E Brusamolino, S Burcheri, A Ambrosetti, M Merli, E Bonoldi, M Chilosi, A Viglio, M Lazzarino, et al.
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
Ann. Onc.,
September 1, 2006;
17(9):
1434 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. De Re, S. De Vita, D. Sansonno, D. Gasparotto, M. P. Simula, F. A. Tucci, A. Marzotto, M. Fabris, A. Gloghini, A. Carbone, et al.
Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses
Rheumatology,
June 1, 2006;
45(6):
685 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. M. Ferreri, E. Viale, M. Guidoboni, A. G. Resti, C. De Conciliis, L. Politi, A. A. Lettini, F. Sacchetti, R. Dolcetti, C. Doglioni, et al.
Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
Ann. Onc.,
May 1, 2006;
17(5):
769 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Besson, D. Canioni, E. Lepage, S. Pol, P. Morel, P. Lederlin, A. Van Hoof, H. Tilly, P. Gaulard, B. Coiffier, et al.
Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus-Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs
J. Clin. Oncol.,
February 20, 2006;
24(6):
953 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Mitterlechner, M Fiegl, H Muhlbock, W Oberaigner, S Dirnhofer, and A Tzankov
Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000
J. Clin. Pathol.,
January 1, 2006;
59(1):
48 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rosa, G. Saletti, E. De Gregorio, F. Zorat, C. Comar, U. D'Oro, S. Nuti, M. Houghton, V. Barnaba, G. Pozzato, et al.
Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
PNAS,
December 20, 2005;
102(51):
18544 - 18549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J.M. Ferreri, M. Ponzoni, M. Guidoboni, C. De Conciliis, A. G. Resti, B. Mazzi, A. A. Lettini, J. Demeter, S. Dell'Oro, C. Doglioni, et al.
Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci-Eradicating Antibiotic Therapy
J. Clin. Oncol.,
August 1, 2005;
23(22):
5067 - 5073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Carbonari, E. Caprini, T. Tedesco, F. Mazzetta, V. Tocco, M. Casato, G. Russo, and M. Fiorilli
Hepatitis C Virus Drives the Unconstrained Monoclonal Expansion of VH1-69-Expressing Memory B Cells in Type II Cryoglobulinemia: A Model of Infection-Driven Lymphomagenesis
J. Immunol.,
May 15, 2005;
174(10):
6532 - 6539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vallisa, P. Bernuzzi, L. Arcaini, S. Sacchi, V. Callea, R. Marasca, A. Lazzaro, E. Trabacchi, E. Anselmi, A. L. Arcari, et al.
Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience
J. Clin. Oncol.,
January 20, 2005;
23(3):
468 - 473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Saadoun, F. Suarez, F. Lefrere, F. Valensi, X. Mariette, A. Aouba, C. Besson, B. Varet, X. Troussard, P. Cacoub, et al.
Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?
Blood,
January 1, 2005;
105(1):
74 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. McKeating, L. Q. Zhang, C. Logvinoff, M. Flint, J. Zhang, J. Yu, D. Butera, D. D. Ho, L. B. Dustin, C. M. Rice, et al.
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
J. Virol.,
August 15, 2004;
78(16):
8496 - 8505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Morton, E. A. Engels, T. R. Holford, B. Leaderer, Y. Zhang, S. H. Zahm, P. Boyle, B. Zhang, S. Flynn, G. Tallini, et al.
Hepatitis C Virus and Risk of Non-Hodgkin Lymphoma: A Population-Based Case-Control Study among Connecticut Women
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2004;
13(3):
425 - 430.
[Abstract]
[Full Text]
|
 |
|
|
|